Organon & Co.

Ticker

OGN

ISIN

US68622V1061

Price

USD 21.80

Change Today

+0.28 / 1.301 %

Price 1 year ago

19.51 / 11.755 %

Market Capitalization

7,641,996,800.00

52 Week Low

10.64

52 Week High

22.25

200 Day Moving Average

16.58

50-day Moving Average

18.59


Price evolution

Yearly Returns


Peers


Peers

Company information

Summary

Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzys, Renflexis, and Hadlima, as well as two oncology products, including Ontruzant and Aybintio. It also offers cardiovascular products, consisting of several cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypertension; respiratory products for various treatments to control and prevent symptoms caused by asthma under the Singulair, Dulera, Zenhale, and Asmanex brand names; and Singulair, Nasonex, Clarinex, and Aerius for treating seasonal allergic rhinitis. In addition, the company provides dermatology products under the Diprosone and Elocon brand; bone health portfolio, including Fosamax brand name; non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brand names; Proscar for the treatment of symptomatic benign prostatic hyperplasia; and Propecia for the treatment of male pattern hair loss. The company sells its products primarily to drug wholesalers and retailers, hospitals, and government agencies, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was incorporated in 2020 and is based in Jersey City, New Jersey.

Sector

Healthcare

Industry

Drug Manufacturers—General

Country

United States

Exchange

NYQ

Earnings Per Share

5.975

P/E Ratio

5.0443516

Debt/Equity Ratio

-

Beta

-

City

Jersey City

Address

30 Hudson Street

Zip

07302

Ebitda

2,100,000,000.00

Ebitda Margins

0.33

Enterprise to Ebitda

7.83

Enterprise Value

16,445,371,392.00

Target Price

38.57

Estimated Price

-

Book Value

-6.38

Expected Growth

-

Balance sheet

Income statement

Sustainability

Correlation

Company Name Correlation
600436.SS ZHANGZHOU PIENTZEHUANG PHARMACE -0.18
600771.SS GUANGYUYUAN CHINESE HERBAL MEDI -0.17
PFE Pfizer, Inc. -0.06
ECILC.IS ECZACIBASI ILAC -0.05
600276.SS JIANGSU HENGRUI MEDICAL CO LTD -0.04
600572.SS ZHEJIANG CONBA PHARMACEUTICAL C -0.02
KLBF.JK Kalbe Farma Tbk. -0.00
600867.SS TONGHUA DONGBAO MEDICINES CO LT 0.04
2186.HK LUYE PHARMA 0.10
LLY Eli Lilly and Company 0.10
300006.SZ CHONGQING LUMMY PH 0.10
HZNP Horizon Therapeutics Public Lim 0.12
4519.T CHUGAI PHARMACEUTICAL CO 0.12
600613.SS SHANGHAI SHENQI PHARM INVEST MA 0.18
4568.T DAIICHI SANKYO COMPANY LIMITED 0.20
GILD Gilead Sciences, Inc. 0.20
4503.T ASTELLAS PHARMA 0.21
GSK.L GSK PLC 0.23
ABBV AbbVie Inc. 0.24
MYX.AX M PHARMA FPO 0.24
600713.SS NANJING PHARMACEUTICAL CO LTD 0.27
MRK Merck & Company, Inc. 0.30
JNJ Johnson & Johnson 0.35
NOVN.SW NOVARTIS N 0.35
1093.HK CSPC PHARMA 0.36
BMY Bristol-Myers Squibb Company 0.38
AZN Astrazeneca PLC 0.38
GSK GSK plc 0.40
AMGN Amgen Inc. 0.48

Similar companies

Ticker Name City Country Currency Exchange Beta EV/EBITDA Employees Site
600276.SS JIANGSU HENGRUI MEDICAL CO LTD Lianyungang China CNY SHH 58.73 24491 https://www.hrs.com.cn
KLBF.JK Kalbe Farma Tbk. Jakarta Indonesia IDR JKT 0.50 14.50 12392 https://www.kalbe.co.id
1093.HK CSPC PHARMA Shijiazhuang China HKD HKG 0.67 12.86 24746 https://www.cspc.com.hk
300006.SZ CHONGQING LUMMY PH Chongqing China CNY SHZ 0.83 -32.33 935 https://www.cqlummy.com
PFE Pfizer, Inc. New York United States USD NYQ 0.68 6.88 79000 https://www.pfizer.com
600572.SS ZHEJIANG CONBA PHARMACEUTICAL C Hangzhou China CNY SHH 0.46 10.69 8589 https://www.conbagroup.com
600713.SS NANJING PHARMACEUTICAL CO LTD Nanjing China CNY SHH 0.46 9.37 5062 https://www.njyy.com
600867.SS TONGHUA DONGBAO MEDICINES CO LT Tonghua China CNY SHH 0.24 12.42 https://www.thdb.com
ECILC.IS ECZACIBASI ILAC Istanbul Turkey TRY IST 0.20 71.70 336 https://www.eczacibasi.com.tr/en/eczacibasi-gruop/companies/other-products-and-services
GSK.L GSK PLC Brentford United Kingdom GBp LSE 0.32 6.22 90096 https://www.gsk.com
MRK Merck & Company, Inc. Kenilworth United States USD NYQ 0.36 10.37 67000 https://www.merck.com
BMY Bristol-Myers Squibb Company New York United States USD NYQ 0.44 8.87 32200 https://www.bms.com
600771.SS GUANGYUYUAN CHINESE HERBAL MEDI Xi'an China CNY SHH 0.55 -48.11 1900 https://www.guangyuyuan.com
GILD Gilead Sciences, Inc. Foster City United States USD NMS 0.39 7.19 14400 https://www.gilead.com
JNJ Johnson & Johnson New Brunswick United States USD NYQ 0.57 14.45 141700 https://www.jnj.com
GSK GSK plc Brentford United Kingdom USD NYQ 0.18 8.08 90096 https://www.gsk.com
AZN Astrazeneca PLC Cambridge United Kingdom USD NMS 0.12 18.55 83100 https://www.astrazeneca.com
ABBV AbbVie Inc. North Chicago United States USD NYQ 0.75 11.46 50000 https://www.abbvie.com
2186.HK LUYE PHARMA Yantai China HKD HKG 0.75 14.06 4845 https://www.luye.cn
600613.SS SHANGHAI SHENQI PHARM INVEST MA Shanghai China CNY SHH 0.36 22.96 1371 https://www.gzsq.com
MYX.AX M PHARMA FPO Salisbury South Australia AUD ASX 1.09 27.98 https://www.maynepharma.com
4568.T DAIICHI SANKYO COMPANY LIMITED Tokyo Japan JPY JPX 52.12 16458 https://www.daiichisankyo.com
4503.T ASTELLAS PHARMA Tokyo Japan JPY JPX 0.58 12.39 14522 https://www.astellas.com
NOVN.SW NOVARTIS N Basel Switzerland CHF EBS 0.50 10.30 108000 https://www.novartis.com
SNY Sanofi Paris France USD NMS 0.36 9.75 95442 https://www.sanofi.com
HZNP Horizon Therapeutics Public Lim Dublin Ireland USD NMS 1.16 20.67 1940 https://www.horizontherapeutics.com
LLY Eli Lilly and Company Indianapolis United States USD NYQ 0.37 29.00 35000 https://www.lilly.com
AMGN Amgen Inc. Thousand Oaks United States USD NMS 0.58 12.61 24200 https://www.amgen.com
4519.T CHUGAI PHARMACEUTICAL CO Tokyo Japan JPY JPX 0.64 9.60 7664 https://www.chugai-pharm.co.jp
600436.SS ZHANGZHOU PIENTZEHUANG PHARMACE Zhangzhou China CNY SHH 0.78 57.53 2591 https://www.zzpzh.com.cn
BAYN.DE BAYER AG Leverkusen Germany EUR GER 1.16 13.66 101914 https://www.bayer.com
AZN.L ASTRAZENECA PLC ORD SHS $0.25 Cambridge United Kingdom GBp LSE 0.10 15.96 83100 https://www.astrazeneca.com
300357.SZ ZHEJIANG WOLWO BIO Huzhou China CNY SHZ 0.40 56.57 1488 https://www.wolwobiotech.com
SAN.PA SANOFI Paris France EUR PAR 0.36 9.86 95442 https://www.sanofi.com
NVS Novartis AG Basel Switzerland USD NYQ 0.49 10.62 108000 https://www.novartis.com
0P6S.IL BAYER AG Leverkusen Germany EUR IOB 1.15 9.51 100753 https://www.bayer.com
CIPLA.NS CIPLA LTD Mumbai India INR NSI 17.91 https://www.cipla.com
4528.T ONO PHARMACEUTICAL CO Osaka Japan JPY JPX 0.33 13.40 3687 https://www.ono-pharma.com
4536.T SANTEN PHARMACEUTICAL CO Osaka Japan JPY JPX 0.37 7.05 4315 https://www.santen.com
OGN Organon & Co. Jersey City United States USD NYQ 7.83 9300 https://www.organon.com

Funds


Mutual Fund Holders

Social

Dividends

Ratings

News

Earnings

SEC Filings

Options

Indicators

Glossary
Momentum
A technical indicator that measures the rate of change in price movements over a specific period. It indicates the strength or weakness of a price trend.
Assessment: A positive momentum value generally indicates a good trend, while a negative value suggests a weak or downward trend.
Inertia
In trading, inertia refers to the tendency of prices to continue moving in their current direction. It suggests that an asset's price will likely maintain its current trend.
Assessment: A higher inertia value is generally considered good, as it indicates a strong and sustained price trend.
Relative Strength Index (RSI)
A momentum oscillator that measures the speed and change of price movements. It helps identify overbought or oversold conditions in an asset.
Assessment: An RSI value above 70 is typically considered overbought and may suggest a potential reversal or correction. Conversely, an RSI value below 30 is often considered oversold, indicating a possible upward price correction.
Fibonacci's Weighted Moving Average
A technical indicator that assigns different weights to recent data points, giving more significance to recent prices. It helps smooth out price fluctuations and identify trend reversals.
Assessment: The interpretation of the Fibonacci's Weighted Moving Average value depends on its comparison to other moving averages or trendlines. A value above 50 may indicate an uptrend, while a value below 50 may suggest a downtrend.
Williams %R
A momentum indicator that measures overbought or oversold conditions in an asset. It shows the relationship of the current closing price to the high-low range over a specified period.
Assessment: Williams %R values above -20 are typically considered overbought and may indicate a potential price reversal. Values below -80 are often viewed as oversold, suggesting a potential price bounce.
Relative Volatility Index (RVI)
A technical indicator that measures the volatility of a security by comparing the magnitude of recent price movements to the magnitude of average price changes. It helps identify periods of high or low volatility.
Assessment: A higher RVI value suggests higher volatility, which can provide trading opportunities but also carries increased risk.
Commodity Channel Index (CCI)
A versatile indicator that measures the current price level relative to an average price level over a given period. It helps identify overbought or oversold conditions and potential trend reversals.
Assessment: CCI values above 100 are often considered overbought, indicating a potential price correction or reversal. Values below -100 are typically viewed as oversold, suggesting a potential price rebound.